Impact of Telemedicine on Delivery of Pediatric Inflammatory Bowel Disease Care
Hilary K. Michel, Tyler J. Gorham, Jennifer A. Lee, Swan Bee Liu, Molly Wright, Ross M. Maltz, Jennifer L. Dotson- Gastroenterology
- Pediatrics, Perinatology and Child Health
Objectives:
Outpatient inflammatory bowel disease (IBD) care shifted from office visits (OVs) to a model with integrated telemedicine during the 2020 COVID-19 pandemic. We describe the impact of this shift on delivery of pediatric IBD care.
Methods:
We collected electronic medical record data from office and telemedicine visits for pediatric patients with IBD at a single center from April 2019 to December 2020. We compared visit volume, duration, and test ordering between 2019 and 2020, and between OV and telemedicine, and assessed for differences in telemedicine adoption by sociodemographic factors.
Results:
Visit volume was maintained between 2019 and 2020. Median overall appointment time was shorter for telemedicine versus OV [46 (interquartile range, IQR 35–72) vs 62 (IQR 51–80) minutes;
Conclusions:
Integrated telemedicine allowed for continued delivery of pediatric IBD care and significantly decreased appointment time. While telemedicine may improve access for those who live further from the office, concerns remain about the introduction of disparities.